Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Esbriet, pirfenidone (Pirespa) (S-7701)
print preview
bookmark
share with colleague
General Information
Company
InterMune Inc.
Description
Small molecule inhibitor of proinflammatory cytokines such as tumor necrosis factor (TNF) alpha and IL-1 beta, as well as pro-fibrotic cytokines, including platelet derived growth factor (PDGF) and transforming growth factor (TGF) beta
Molecular Target
Tumor necrosis factor (TNF) alpha
;
Transforming growth factor (TGF) beta 1 (TGFB1)
Mechanism of Action
MAP kinase (p38) inhibitor
Latest Stage of Development
Marketed
Indication
Pulmonary fibrosis
Partner
Ildong Pharmaceutical Co. Ltd.
;
Shionogi & Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy